SAN DIEGO--(BUSINESS WIRE)--Cardea Bio, Inc., a Tech+Bio company integrating molecular biology with semiconductors via Graphene-based biology-gated Transistors, announced today a $6.5M series A ...
SAN DIEGO, March 25, 2019 /PRNewswire-PRWeb/ -- Cardea Bio, leading manufacturer of commercial-quality graphene digital biosensors, together with Nanosens Innovations, introduces the new CRISPR-Chip ...
SAN DIEGO--(BUSINESS WIRE)--Cardea Bio, a Tech+Bio company integrating molecular biology with semiconductor electronics, has signed a commercial partnership with Scentian Bio. Scentian is an expert in ...
SAN DIEGO, Aug. 25, 2022 /PRNewswire/ -- As part of the Semiconductor Research Corporation (SRC) being selected by NIST's Advanced Manufacturing Office to define the future of Microelectronics and ...
SAN DIEGO, April 5, 2022 /PRNewswire/ -- Today, Cardea Bio, Inc. - the world's only mass producer of biocompatible semiconductors - announced a significant milestone with the launch of CRISPR QC Inc.
San Diego-based Cardea Bio, which is integrating biology with modern electronics, said today it has received a $1.1 million grant from the Bill & Melinda Gates Foundation to fund work that someday ...
SAN DIEGO, Jan. 9, 2020 /PRNewswire-PRWeb/ -- Cardea Bio, a new (bio)technology infrastructure company pioneering the development of biology-gated transistors to integrate biology and electronics, ...